Advancements in ADHD Research and Treatment: What It Means for Patients

The landscape of ADHD research and treatment is rapidly evolving, bringing new insights and innovations that enhance our ability to support you.
At The ADHD Centre, we are committed to staying at the forefront of these developments, ensuring our patients receive the most advanced and effective care.
Whether through cutting-edge diagnosis, personalised treatment plans, or holistic lifestyle interventions, we strive to make a meaningful difference in the lives of those we work with.
While the exact cause of ADHD remains complex, it is believed to result from a combination of genetic, environmental, and neurological factors. Traditionally, treatment has involved a combination of medication, behavioural therapy, and educational interventions.
Here, we highlight some of the latest developments in ADHD research and how they could benefit you.
Advances in ADHD Research

Genetic and Neurobiological Discoveries
One of the most exciting areas of ADHD research involves genetics and neurobiology. Advances in genetic studies have identified several genes associated with ADHD, providing insight into the hereditary nature of the disorder. For instance, studies have pinpointed gene variations related to dopamine regulation, crucial for attention and behaviour control.
Neuroimaging technologies, such as functional MRI (fMRI) and PET scans, have revealed differences in the brain structure and function of those with ADHD. These discoveries help us understand the underlying neurobiological mechanisms of ADHD and pave the way for more targeted treatments.
Improved Diagnostic Tools
Accurate diagnosis is the cornerstone of effective ADHD treatment. Recent advancements in diagnostic tools and criteria enhance our ability to identify ADHD more accurately. For example, developing digital assessment tools and apps allows real-time tracking of symptoms and behaviours. These tools provide a more comprehensive picture of an individual's condition, enabling more precise diagnoses.
Additionally, machine learning algorithms are being used to analyse large datasets of patient information, identifying patterns and predictors of ADHD. This technology not only improves diagnostic accuracy but also helps in tailoring personalised treatment plans.
At The ADHD Centre, we carry out all our diagnostic ADHD assessments and medication titrations by highly experienced medical doctors. These are consultant psychiatrists and experts in the field of mental health. Find out more HERE.
Non-Pharmacological Interventions
While medication remains a fundament of ADHD treatment, there is growing interest in non-pharmacological interventions. Research highlights the effectiveness of various alternative therapies, such as neurofeedback, cognitive-behavioural therapy (CBT), and mindfulness-based interventions.
Neurofeedback involves training individuals to regulate their brain activity, which can improve attention and reduce hyperactivity. Studies have shown promising results, suggesting that neurofeedback can be a valuable addition to traditional treatments.
Cognitive-behavioural therapy has long been used to address the behavioural aspects of ADHD. Recent advancements in CBT techniques, particularly those tailored for ADHD, are proving to be highly effective in helping patients develop coping strategies and organisational skills.
Mindfulness focus’ on improving attention and self-regulation through mindfulness practices. Research indicates that these interventions can reduce ADHD symptoms and enhance overall well-being. We offer an online mindfulness course designed to improve executive function. Find out more about it HERE.
Pharmacological Innovations
treatment. Recent innovations include extended-release formulations that provide consistent symptom control throughout the day, reducing the need for multiple doses and improving adherence.
Moreover, new medications with different mechanisms of action are being explored. For instance, non-stimulant medications that target other neurotransmitter systems offer alternative options for patients who may not respond well to traditional stimulant medications.
Psychiatric pharmacogenomic testing can also help determine the appropriate ADHD medication dosage for children. This genetic test offers insights into a child's metabolism genes, particularly the CYP450 genes, which are crucial in how medications are processed in the body.
Using this testing, clinicians can tailor ADHD treatment plans based on a child’s genetic profile, medical history, lifestyle, and other relevant factors. The test helps identify the optimal dosage required, considering individual differences in medication metabolism. For more information on this, CLICK HERE
Lifestyle and Nutritional Interventions
Emerging research underscores the importance of lifestyle factors and nutrition in managing ADHD symptoms. Studies suggest that regular physical activity can significantly reduce ADHD symptoms by enhancing brain function and improving mood. We encourage patients to incorporate exercise into their daily routines as part of a holistic treatment plan.
Nutritional interventions, such as omega-3 fatty acid supplementation, have also shown promise. Omega-3 fatty acids are essential for brain health, and research indicates they may help improve attention and reduce hyperactivity in individuals with ADHD.
Benefits for Patients

Advancements in ADHD research enable us to develop highly personalised treatment plans. By understanding each patient's condition's genetic, neurobiological, and behavioural aspects, we can tailor interventions to their specific needs. This personalised approach increases the likelihood of treatment success and improves overall quality of life.
Improved diagnostic tools and techniques allow for more accurate identification of ADHD, reducing the risk of misdiagnosis. Early and precise diagnosis is crucial, particularly for children and students, as it enables timely intervention and support. Accurate diagnosis also helps adults understand their symptoms and seek appropriate treatment, which can significantly improve their personal and professional lives.
Expanding treatment options, including non-pharmacological and lifestyle interventions, provide patients with a broader range of choices. This is particularly beneficial for those who may experience side effects from medication or prefer alternative therapies. The ability to combine different treatment modalities enhances overall treatment efficacy.
Advances in ADHD research empower patients with knowledge about their condition. Understanding the genetic and neurobiological basis of ADHD can reduce stigma and promote acceptance. Patients well-informed about their condition are more likely to engage actively in their treatment and make informed decisions about their health.
Ultimately, the goal of ADHD treatment is to improve the quality of life for anyone affected by ADHD. The latest research and treatment advancements offer hope and possibilities for achieving this goal. By addressing the diverse needs of our patients, we help them thrive academically, professionally, and socially.
Research Projects

In collaboration with national and international partners, researchers from Aarhus University made significant progress in understanding ADHD through a ground-breaking study published in Nature Genetics last year. Analysing over six million genetic variants in 38,691 individuals with ADHD and 186,843 without, they identified 27 genetic risk variants associated with the disorder—more than twice as many as previously known. These risk genes are mainly expressed in the brain and neurons, offering more profound insights into the neurodevelopmental underpinnings of ADHD.
In May this year, researchers at Boston University Chobanian & Avedisian School of Medicine announced a new initiative to improve the detection and evaluation of ADHD.
According to the researchers, their initiative, which involved distributing diagnostic rating scales to these families, improved clinician recognition of positive screens for attention problems and follow-up evaluation for ADHD. A study jointly led by the University of Surrey and the Hebrew University of Jerusalem found that non-invasive brain stimulation, when combined with cognitive training, can alleviate symptoms of ADHD in children.
In a clinical trial with 23 unmedicated children (six to 12 years old) with ADHD, researchers tested whether mild brain stimulation combined with cognitive training could improve symptoms. After a two-week program, 55% of children receiving actual brain stimulation showed significant improvements, compared to 17% in the placebo group, as reported by their parents.
ADHD Support
The ADHD Centre has a team of medical professionals who have worked with ADHD patients for decades. We understand the challenges of the condition and how ADHD can impact your life.
Whether you’re an adult, a student, or the parent of a child with ADHD, we can offer support and treatment to help you manage and cope with the challenges ADHD can bring.
For more information on how we can help you:
Call 0800 061 4276
Email enquiries@adhdcentre.co.uk
Follow us on social media. You can find us on Facebook or Instagram
Book an ADHD assessment for an adult or child HERE
